Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane

Brain Research
B S BasavarajappaB L Hungund

Abstract

The effects of chronic ethanol (EtOH) consumption on the central nervous system may be related in part to its action on biological membranes by altering various receptor functions. In the current study, we examined the effects of chronic EtOH (4 day inhalation) on cannabinoid receptors (CB1) labeled with [3H]CP55,940 in synaptic plasma membranes (SPM) isolated from mouse brain. Our results indicate the presence of a high level of CB1 receptors in controls (Bmax=12.0+/-0.3 pmol mg-1 protein) which decreased significantly (-58%) in SPM from mouse brain chronically exposed to EtOH. This effect occurs without any changes in the receptor affinity (Kd=2. 3+/-0.3 nM for control and 2.9+/-0.3 nM for EtOH group, P>0.05). Dissociation kinetic results showed a dissociation rate constant (K-1) of 0.09+/-0.01 min-1 for control and this dissociation rate constant decreased significantly in the chronic EtOH treated mice brain (0.05+/-0.01 min-1, P<0.05). The competition studies with anandamide resulted in a substantial decrease in [3H]CP55,940 binding in both the control and EtOH group, with a decrease (P<0.05) in the Ki values in the SPM of chronic EtOH exposed mice. Hill transformation analysis showed an nH close to one in control (0. 92+/-...Continue Reading

References

Jan 1, 1990·Annals of Medicine·D M LovingerF F Weight
Feb 13, 1990·European Journal of Pharmacology·K A GrantB Tabakoff
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P D SuzdakS M Paul
Mar 31, 1989·Science·D M LovingerF F Weight
May 15, 1989·Experientia·M E Charness
Dec 11, 1989·Biochimica Et Biophysica Acta·S A FormanK W Miller
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A S GordonI Diamond
Jan 1, 1988·Life Sciences·W G Wood, F Schroeder
Aug 1, 1988·Biochemical Pharmacology·B L HungundT B Cooper
Sep 22, 1986·Life Sciences·F R GeorgeA C Collins
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·A C Howlett
Nov 1, 1994·Addiction·J Littleton, H Little
Jan 1, 1994·Pharmacology, Biochemistry, and Behavior·F Rodríguez de FonsecaJ A Ramos
Feb 11, 1994·Biochemical Pharmacology·S R ChildersM B Roy
Mar 26, 1998·Biochemical Pharmacology·B S BasavarajappaB L Hungund

❮ Previous
Next ❯

Citations

Jul 3, 2019·British Journal of Pharmacology·Balapal S BasavarajappaShivakumar Subbanna
Oct 1, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sara PeñascoPedro Grandes
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Roberto RimondiniMarkus Heilig
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Javier Fernández-SolariValeria Rettori
Feb 17, 2007·The Biochemical Journal·Belen FerrerFernando Rodríguez de Fonseca
Jan 6, 2010·The International Journal of Neuropsychopharmacology·Francisco AlénJosé Antonio López-Moreno
Oct 21, 2010·Alcoholism, Clinical and Experimental Research·Panayotis K ThanosNora D Volkow
Oct 31, 2018·Drugs·Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Nov 20, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Jorge ManzanaresTomás Palomo
Nov 20, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·F Lallemand, P de Witte
Nov 20, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Balapal S Basavarajappa, Basalingappa L Hungund
May 5, 2005·The European Journal of Neuroscience·Andrea CippitelliUNKNOWN European TARGALC Consortium
Mar 28, 2007·Alcoholism, Clinical and Experimental Research·Somsak MitrirattanakulIgor Spigelman
Sep 18, 2008·Journal of Neurochemistry·Balapal S BasavarajappaOttavio Arancio
Jun 28, 2011·Psychopharmacology·Matthew J PavaJohn J Woodward
May 4, 2012·Alcoholism, Clinical and Experimental Research·Alexander NeumeisterYiyun Huang
Oct 16, 2015·Revista da Associação Médica Brasileira·João Victor Vezali CostardiSônia Valéria Pinheiro Malheiros
Aug 8, 2014·Frontiers in Integrative Neuroscience·Matthew J Pava, John J Woodward
Sep 12, 2015·Neurotoxicity Research·Patrycja KleczkowskaMagdalena Bujalska-Zadrozny
Oct 12, 2005·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Karen L NowakBasalingappa L Hungund
Jan 4, 2001·Japanese Journal of Pharmacology·T Yamamoto, K Takada
Oct 7, 2004·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Frédéric LallemandPhilippe De Witte
Jun 5, 2007·Psychopharmacology·Jose Inácio LemosGina Struffaldi Morato
May 8, 2013·Alcoholism, Clinical and Experimental Research·Cássia C CoelhosoJair G Santos-Junior
Jun 28, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Benjamin A HarlanArthur C Riegel
Sep 22, 2006·Journal of Neurochemistry·Sabah KelaïLaurence Lanfumey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.